These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

520 related items for PubMed ID: 10829251

  • 21. Lipid and non-lipid effects of statins.
    Paoletti R, Bolego C, Cignarella A.
    Handb Exp Pharmacol; 2005; (170):365-88. PubMed ID: 16596807
    [Abstract] [Full Text] [Related]

  • 22. Cardiovascular disease: C-reactive protein and the inflammatory disease paradigm: HMG-CoA reductase inhibitors, alpha-tocopherol, red yeast rice, and olive oil polyphenols. A review of the literature.
    Patrick L, Uzick M.
    Altern Med Rev; 2001 Jun; 6(3):248-71. PubMed ID: 11410071
    [Abstract] [Full Text] [Related]

  • 23. Efficacy of cholesterol-lowering treatment in Japanese elderly patients with coronary artery disease and normal cholesterol level using 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitor.
    Chikamori T, Sugimoto K, Hamada T, Kitaoka H, Furuno T, Seo H, Doi Y.
    J Cardiol; 2000 Feb; 35(2):95-101. PubMed ID: 10713930
    [Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. Lipid lowering drugs in atherosclerosis--the HMG-CoA reductase inhibitors.
    Mantell G.
    Clin Exp Hypertens A; 1989 Feb; 11(5-6):927-41. PubMed ID: 2676263
    [Abstract] [Full Text] [Related]

  • 27. Atorvastatin in the treatment of primary hypercholesterolemia and mixed dyslipidemias.
    Yee HS, Fong NT.
    Ann Pharmacother; 1998 Oct; 32(10):1030-43. PubMed ID: 9793596
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. Beyond the laboratory: clinical implications for statin pleiotropy.
    Halcox JP, Deanfield JE.
    Circulation; 2004 Jun 01; 109(21 Suppl 1):II42-8. PubMed ID: 15173062
    [Abstract] [Full Text] [Related]

  • 36. Pitavastatin: novel effects on lipid parameters.
    Chapman MJ.
    Atheroscler Suppl; 2011 Nov 01; 12(3):277-84. PubMed ID: 22152282
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. [Prevention and therapy of vascular damage and endothelial dysfunction with hypocholesteremic agents].
    De Caterina R, Lenzi S.
    G Ital Cardiol; 1998 Feb 01; 28(2):168-77. PubMed ID: 9534058
    [Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 26.